VIJAYA

ANASOOYADEVIATHRISON
Posted September 26, 2017 from United States

" www.nih.gov.National Institutes of Health (NIH) is amedical research agency,omponent of the U.S. Department of Health and Human Services.National Cancer Institute (NCI) is aCancer Program and leads NIH’s efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, www.cancer.gov. ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) is a scientific organization that designs and conducts cancer research involving adults who have or are at risk of developing cancer. www.ecog-acrin.org(link is external).The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of digital mammography for breast cancer screening isopen for enrollment. Researchers are enrolling healthy women ages 45 to 74 who are already planning to get routine mammogramsto most effectively screen women for breast cancer and help women make informed decisions about the screening tests in the future. Researchers are comparing two types of digital mammography tomosynthesis (known as three-dimensional, or 3-D) and conventional (two-dimensional, or 2-D). Although 3-D mammography, being the newer technology, is likely to detect more findings that require follow-up, it is also likely to lead to more procedures and treatments. It is not known if this newer mammography technology is reducing a woman’s risk of developing a life-threatening (advanced) cancer compared with 2-D mammography. The trial aims to find out.Researchers are collecting data on the results of every mammogram, whether the imaging shows no signs of cancer, findings suspicious of cancer, or a breast cancer. Any medical follow-ups, such as more imaging or biopsies, are also being reported. Researchers intend to follow all participants for breast cancer status, treatment, and outcomes. The vast majority of women in the study will not develop breast cancer. If a woman does receive a diagnosis of any kind of breast cancer while in the trial, she will receive treatment.In addition to data from mammograms, the trial is building a biorepository for future research on genetic markers for breast cancer by asking all participants to voluntarily submit blood samples and swabs of cells from inside the mouth (buccal cells) which could help women and their doctors decide the best ways to screen for breast cancer by evaluating their individual risk factors for developing the disease."

Comments 4

Log in or register to post comments
Jill Langhus
Sep 27, 2017
Sep 27, 2017

Hi there. Thanks for sharing your story about a new mammography study. I don't trust the old way of doing mammography and refuse to do it, personally. I have seen to many results saying that it doesn't help and can even cause cancer, so if they are looking at doing a new, improved version then that's probably a good thing. Personally I would opt for thermography first.

ANASOOYADEVIATHRISON
Sep 27, 2017
Sep 27, 2017

JLANGHUS : Thank You . Best Wishes.

krishna

Urmila Chanam
Oct 02, 2017
Oct 02, 2017

Dear Aarbeekayathrison,

Thank you for sharing important information on breast cancer testing, diagnosis and treatment. So less is known about it and in India, women have very bad health seeking behavior so these posts are so important. Please keep writing on World Pulse and let the women from 190 countries on this platform benefit.

Much love and regards,

Urmila Chanam

ANASOOYADEVIATHRISON
Oct 03, 2017
Oct 03, 2017

Srimathi Urmila Chanam : Thanks Best Wishes namasthey ;

From New / No Moon Amaavaasya , progress step by step 15 steps to Full Moon PaurNamaasya PoorNima Punnami Best Wishes From RVKLKBKM .

Related Stories

Lulabi Pattanayak
Meyanwieh Diana Queency